These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 24243499)
1. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499 [TBL] [Abstract][Full Text] [Related]
2. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733 [TBL] [Abstract][Full Text] [Related]
3. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Stemberger S; Poewe W; Wenning GK; Stefanova N Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy. Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F Cells; 2020 Oct; 9(11):. PubMed ID: 33138150 [TBL] [Abstract][Full Text] [Related]
6. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404 [TBL] [Abstract][Full Text] [Related]
7. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Heras-Garvin A; Weckbecker D; Ryazanov S; Leonov A; Griesinger C; Giese A; Wenning GK; Stefanova N Mov Disord; 2019 Feb; 34(2):255-263. PubMed ID: 30452793 [TBL] [Abstract][Full Text] [Related]
8. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942 [TBL] [Abstract][Full Text] [Related]
9. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies. Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527 [TBL] [Abstract][Full Text] [Related]
10. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Masui K; Nakata Y; Fujii N; Iwaki T Neuropathology; 2012 Feb; 32(1):69-76. PubMed ID: 21615514 [TBL] [Abstract][Full Text] [Related]
11. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103 [TBL] [Abstract][Full Text] [Related]
12. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074 [TBL] [Abstract][Full Text] [Related]
13. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584 [TBL] [Abstract][Full Text] [Related]
14. Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype. Kuzdas-Wood D; Irschick R; Theurl M; Malsch P; Mair N; Mantinger C; Wanschitz J; Klimaschewski L; Poewe W; Stefanova N; Wenning GK PLoS One; 2015; 10(10):e0136575. PubMed ID: 26496712 [TBL] [Abstract][Full Text] [Related]
18. The role of alpha-synuclein in the pathogenesis of multiple system atrophy. Wenning GK; Jellinger KA Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181 [TBL] [Abstract][Full Text] [Related]
19. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method. Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540 [TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy. Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]